Not available
Quote | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Last: | $1.47 |
---|---|
Change Percent: | 0.0% |
Open: | $1.41 |
Close: | $1.47 |
High: | $1.47 |
Low: | $1.38 |
Volume: | 891,701 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Atossa Therapeutics Inc. (NASDAQ:ATOS)
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...
2024-07-11 07:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the more exciting yet admittedly risky types of investing is buying into cheap drug developer stocks early in their company life cycle. That’s because the world of drug developmen...
Message Board Posts | Atossa Therapeutics Inc. (NASDAQ:ATOS)
Subject | By | Source | When |
---|---|---|---|
Wow. No comments? | killrEngineer | investorshub | 06/28/2023 2:55:37 PM |
MomentumIts trading | 4MVault | investorshub | 06/26/2023 2:08:03 PM |
$ATOS Lets go go go go... Up up and away we go. | DrHarleyboy | investorshub | 06/26/2023 10:09:55 AM |
$ATOS bears and bulls | DrHarleyboy | investorshub | 06/26/2023 1:31:57 AM |
$ATOS MomentumIts gaining | willlbone | investorshub | 06/25/2023 2:39:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...